The costs and effectiveness of four HIV counseling and testing strategies in Uganda

AIDS
Nick MenziesJohn M Blandford

Abstract

HIV counseling and testing (HCT) is a key intervention for HIV/AIDS control, and new strategies have been developed for expanding coverage in developing countries. We compared costs and outcomes of four HCT strategies in Uganda. A retrospective cohort of 84 323 individuals received HCT at one of four Ugandan HCT programs between June 2003 and September 2005. HCT strategies assessed were stand-alone HCT; hospital-based HCT; household-member HCT; and door-to-door HCT. We collected data on client volume, demographics, prior testing and HIV diagnosis from project monitoring systems, and cost data from project accounts and personnel interviews. Strategies were compared in terms of costs and effectiveness at reaching key population groups. Household-member and door-to-door HCT strategies reached the largest proportion of previously untested individuals (>90% of all clients). Hospital-based HCT diagnosed the greatest proportion of HIV-infected individuals (27% prevalence), followed by stand-alone HCT (19%). Household-member HCT identified the highest percentage of discordant couples; however, this was a small fraction of total clients (<4%). Costs per client (2007 USD) were $19.26 for stand-alone HCT, $11.68 for hospital-based HCT, $1...Continue Reading

References

Nov 6, 1991·JAMA : the Journal of the American Medical Association·D L HigginsR Johnson
Oct 16, 1996·JAMA : the Journal of the American Medical Association·M C WeinsteinL B Russell
Aug 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·R G DowningM A Rayfield
Nov 4, 1993·Journal of Health Economics·M Johannesson, M C Weinstein
Feb 24, 2001·Lancet·J Nauwelaers
May 10, 2002·Health Policy and Planning·Steven ForsytheCharles Gilks
Aug 4, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Willy A WereRebecca E Bunnell
Apr 29, 2008·Bulletin of the World Health Organization·Rhoda K WanyenzeMoses R Kamya

❮ Previous
Next ❯

Citations

May 1, 2010·AIDS and Behavior·Rhoda K WanyenzeDavid R Bangsberg
Oct 24, 2009·Current HIV/AIDS Reports·Ishani GanguliRochelle P Walensky
Mar 26, 2013·Current HIV/AIDS Reports·Peter CherutichJonathan Mermin
Feb 17, 2010·International Journal of Emergency Medicine·Christian ArbelaezRochelle P Walensky
Jul 17, 2013·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·David KyaddondoAnita Hardon
May 21, 2010·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·S M KieneM Stein
Dec 15, 2012·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Karen KroegerPeter Kilmarx
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ingrid V Bassett, Rochelle P Walensky
Nov 12, 2010·AIDS Patient Care and STDs·Elioda TumwesigyeFred Nuwaha
Jan 18, 2013·Health Policy and Planning·Sarah E RutsteinWilliam C Miller
Nov 10, 2010·AIDS·Catherine A Hankins, Barbara O de Zalduondo
Dec 24, 2013·AIDS·Saeed AhmedUNKNOWN Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women
Jan 25, 2013·AIDS·Joanna Orne-GliemannUNKNOWN Prenahtest ANRS 12127 Study Group
Jul 8, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael D AprilRobin Wood
May 11, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kristina L GrabbeElizabeth Marum
Sep 22, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Anna M MolesworthNeil French
Nov 12, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Rochelle P WalenskyUNKNOWN Cost-Effectiveness of Preventing AIDS Complications-International Investigators
Jul 5, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Benjamin ArmbrusterHans-Peter Kohler
Feb 22, 2012·Sexually Transmitted Infections·Joseph D TuckerFujie Zhang
Aug 4, 2012·Sexually Transmitted Infections·Carol Dayo ObureCharlotte Watts
Sep 29, 2011·BMC Public Health·Juliet N SekandiChristopher C Whalen
Aug 9, 2013·BMC Public Health·Janne KrauseRobert Colebunders
Dec 23, 2011·BMC Health Services Research·James G KahnNavneet Garg
Jan 25, 2013·BMC International Health and Human Rights·Carla Makhlouf ObermeyerUNKNOWN MATCH Study Group
Jul 24, 2010·PLoS Medicine·Scott Kellerman, Shaffiq Essajee
Apr 25, 2013·PloS One·Geofrey Musinguzi, Fred Nuwaha
Jan 18, 2013·HIV/AIDS : Research and Palliative Care·Michael L Scanlon, Rachel C Vreeman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.